Additionally, the study assessed weight and metabolic responses, finding that efinopegdutides tolerability was similar to that of semaglutide, although certain gastrointestinal side effects were more common
From persistent gastrointestinal symptoms to aspiration risk and functional obstruction, these drugs are changing what walks through the ED doors
Emerging therapies, including dual and triple agonists and small-molecule oral formulations, demonstrate how targeting multiple pathways and improving delivery can enhance efficacy and patient convenience
Figure 23: Photograph of Professor Graeme Bell in San Francisco taken by Mitsuko Seino in the parking lot of Chiron Corporation, 1984, credit: Accili, Bell
BMC Musculoskelet
Eating enough protein and fiber helps you stay fuller longer and naturally supports the same satiety pathways GLP-1s target